Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta OncoGxOne

Rosetta Genomics has launched OncoGxOne, Admera Health's next-generation sequencing panel that detects a vast number of genetic alterations implicated in cancer to provide actionable clinical recommendations. OncoGxOne interrogates all types of genomic aberrations in 64 genes, specifically 56 related to targeted cancer therapies and eight related to chemotherapy. The test covers all exons and 5' and 3' UTRs for each gene, as well as introns that harbor potential gene translocation breakpoints, Rosetta said. The laboratory-developed test is performed on formalin-fixed, paraffin-embedded tissue.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.